Australia markets closed

Cytosorbents Corporation (CTSO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8348-0.0748 (-8.22%)
At close: 04:00PM EDT
0.8551 +0.02 (+2.43%)
After hours: 05:03PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-28,507
-28,507
-32,813
-24,559
-7,837
Depreciation & amortisation
2,027
2,027
1,132
1,130
660.788
Stock-based compensation
3,701
3,701
3,800
6,204
4,708
Change in working capital
2,361
2,361
-3,562
641.899
-757.869
Accounts receivable
-
-
-1,288
420.578
-326.86
Inventory
-121.039
-121.039
945.352
-2,351
-461.512
Other working capital
-22,591
-22,591
-34,690
-18,287
-7,290
Other non-cash items
42.857
42.857
-
-
322.812
Net cash provided by operating activities
-21,655
-21,655
-28,234
-14,006
-5,613
Cash flows from investing activities
Investments in property, plant and equipment
-936.236
-936.236
-6,456
-4,281
-1,676
Net cash used for investing activities
-936.236
-936.236
-6,456
-4,281
-1,676
Cash flows from financing activities
Debt repayment
-
-
0
0
-16,411
Common stock issued
14,256
14,256
-
-
80,214
Common stock repurchased
-
-
-40.358
-90
-
Other financing activities
-
-
-
-
-375
Net cash used provided by (used for) financing activities
14,474
14,474
4,960
715.199
66,348
Net change in cash
-8,217
-8,217
-29,993
-17,596
59,189
Cash at beginning of period
23,832
23,832
53,825
71,422
12,232
Cash at end of period
15,615
15,615
23,832
53,825
71,422
Free cash flow
Operating cash flow
-21,655
-21,655
-28,234
-14,006
-5,613
Capital expenditure
-936.236
-936.236
-6,456
-4,281
-1,676
Free cash flow
-22,591
-22,591
-34,690
-18,287
-7,290